EGFR and central nervous system cancer: As to the former, we found that Ink4/Arf−/−; EGFR* tumorigenic astrocytes, despite their overall similarity, display transcriptional specificities that are differentially retained in the gliomas they originate, suggesting that they represent differentially primed entry points of tumorigenesis.